US2022401727A1PendingUtilityA1
Patient control for implantable medical device
Est. expiryAug 9, 2033(~7 yrs left)· nominal 20-yr term from priority
A61B 5/0022A61B 5/4818A61N 1/3611A61N 1/37247A61B 5/4833A61B 5/0031A61N 1/37211A61N 1/37217A61B 5/4836A61N 1/36139
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A patient control is disclosed that facilitates operation of an implantable medical device.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A system comprising:
a first device that stores usage information of a therapy delivered by an implantable medical device to a patient; and a second device including a therapy manager that is configured to titrate therapy settings selected by a titration protocol by sending a control signal to the implantable medical device after analysis of the usage information received from the first device via a network.
22 . The system of claim 21 , wherein the first device is a device external to the patient that communicates with the implantable medical device via a local, wireless connection.
23 . The system of claim 21 , wherein the usage information includes one or more of details regarding times of use, duration of use, and number of days used.
24 . The system of claim 21 , wherein the therapy settings is at least one of an upper allowable therapy limit and a lower allowable therapy intensity limit.
25 . The system of claim 21 , wherein the implantable medical device includes a pulse generator.
26 . The system of claim 21 , wherein the first device includes a user interface.
27 . The system of claim 21 , wherein the control signal is configured to be sent from the therapy manager to the first device and then from the first device to the implantable medical device.
28 . The system of claim 21 , wherein the control signal limits use of the first device.
29 . The system of claim 21 , wherein the first device is a patient remote control configured to selectively communicate commands to the implantable medical device.
30 . The system of claim 21 , wherein the therapy manager is configured to automatically titrate the therapy settings via the titration protocol.
31 . The system of claim 21 , wherein the second device is configured to present the usage information to a clinician, physician, or care manager; further wherein the second device comprises a control portion including the therapy manager.
32 . The system of claim 31 , wherein second device comprises a web-based portal accessible via a cloud computing resource.
33 . The system of claim 21 , wherein the second device comprises at least one of a clinician programming device or a clinician web-based portal accessible via cloud computing resource.
34 . The system of claim 33 , wherein the therapy settings are titrated based on at least one of implantable medical device data and use of the first device.
35 . The system of claim 33 , wherein the first device includes an input that enables the patient to provide input to the automatic titration protocol.
36 . A system comprising:
a first device being a patient remote control that stores usage information of a therapy delivered by an implantable medical device to a patient; and a second device including a therapy manager that is configured to titrate therapy settings selected by a titration protocol by sending a control signal to the implantable medical device after analysis of the usage information received from the first device via a network; wherein the control signal is configured to be sent from the therapy manager to the patient remote and then from the patient remote to the implantable medical device.
37 . The system of claim 36 , wherein the therapy manager is configured to automatically titrate the therapy settings via the titration protocol.
38 . The system of claim 36 , wherein second device comprises a web-based portal accessible via a cloud computing resource.
39 . The system of claim 36 , wherein the first device includes an input that enables the patient to provide input to the automatic titration protocol.
40 . The system of claim 36 , wherein the usage information includes one or more of details regarding times of use, duration of use, and number of days used.Join the waitlist — get patent alerts
Track US2022401727A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.